top of page

LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML

Product details

Registration number: SIN16250P

Classification: Prescription Only

Active ingredients: Levetiracetam

Strength: 100.00mg/ml

Dosage form: INJECTION

Route: INTRAVENOUS

Registrant: RANBAXY (MALAYSIA) SDN. BHD.

ATC code: N03AX14

HSA approval date: 25 June 2021

Manufacturer(s): SUN PHARMACEUTICAL MEDICARE LTD.

Manufacturing country/countries: INDIA

What are the HSA registration number and classification for LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16250P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Levetiracetam

Strength: 100.00mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Registrant: RANBAXY (MALAYSIA) SDN. BHD.

Source for this answer

Which manufacturers and countries are listed for LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): SUN PHARMACEUTICAL MEDICARE LTD.

Manufacturing country/countries: INDIA

Source for this answer

Where can I look up LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16250P or the exact product name LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this LEVIPIL - LEVETIRACETAM INJECTION USP 100MG/ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16250P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page